A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity

Abstract

Intracellular inclusions composed of hyperphosphorylated filamentous tau are a hallmark of Alzheimer’s disease, progressive supranuclear palsy, Pick’s disease and other sporadic neurodegenerative tauopathies. Recent in vitro and in vivo studies have shown that tau aggregates do not only seed further tau aggregation within neurons, but can also spread to neighbouring cells and functionally connected brain regions. This process is referred to as ‘tau propagation’ and may explain the stereotypic progression of tau pathology in the brains of Alzheimer’s disease patients. Here, we describe a novel in vivo model of tau propagation using human P301S tau transgenic mice infused unilaterally with brain extract containing tau aggregates. Infusion-related neurofibrillary tangle pathology was first observed 2 weeks post-infusion and increased in a stereotypic, time-dependent manner. Contralateral and anterior/posterior spread of tau pathology was also evident in nuclei with strong synaptic connections (efferent and afferent) to the site of infusion, indicating that spread was dependent on synaptic connectivity rather than spatial proximity. This notion was further supported by infusion-related tau pathology in white matter tracts that interconnect these regions. The rapid and robust propagation of tau pathology in this model will be valuable for both basic research and the drug discovery process.

Cited by papers we hold 33

• Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy · 2024
  No notice
• Alzheimer’s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression · 2023
  No notice
• Mouse Models of Alzheimer’s Disease · 2022
  No notice
• Tau deposition patterns are associated with functional connectivity in primary tauopathies · 2022
  No notice
• The Role of Glymphatic System in Alzheimer’s and Parkinson’s Disease Pathogenesis · 2022
  No notice
• Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice · 2021
  Not checked
• Cellular and pathological heterogeneity of primary tauopathies · 2021
  No notice
• Impaired glymphatic function and clearance of tau in an Alzheimer’s disease model · 2020
  No notice
• Mechanisms of Pathogenic Tau and Aβ Protein Spreading in Alzheimer’s Disease · 2020
  No notice
• Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease · 2020
  No notice
• Traumatic Brain Injury Induces Tau Aggregation and Spreading · 2019
  No notice
• Tau Pathology in Chronic Traumatic Encephalopathy and Alzheimer's Disease: Similarities and Differences · 2019
  No notice
• Amyloid and tau accumulate across distinct spatial networks and are differentially associated with brain connectivity · 2019
  Not checked
• Dural lymphatics regulate clearance of extracellular tau from the CNS · 2019
  No notice
• Tau PET imaging in neurodegenerative tauopathies—still a challenge · 2019
  No notice
• Mechanisms of secretion and spreading of pathological tau protein · 2019
  No notice
• Targeting the Synapse in Alzheimer’s Disease · 2019
  No notice
• Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody · 2019
  No notice
• Differentiation of mild cognitive impairment using an entorhinal cortex-based test of virtual reality navigation · 2019
  No notice
• Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain · 2018
  No notice

and 13 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.